Shortages of ADHD medication in Australia
Australia is currently grappling with significant shortages of ADHD medications, particularly those containing methylphenidate hydrochloride, such as Concerta, Ritalin LA, Rubifen LA, and Teva-XR. These shortages are expected to persist until at least the end of 2025, with some products anticipated to be scarce into 2026 .
Key Medications Affected
- Concerta: All strengths (18 mg, 27 mg, 36 mg, 54 mg) are in limited supply due to manufacturing issues, with shortages projected to last until December 31, 2025.
- Methylphenidate-Teva XR: Experiencing shortages across all strengths, attributed to increased demand following the unavailability of other methylphenidate products.
- Ritalin LA and Rubifen LA: Various strengths are in shortage or anticipated to be, with some expected to be scarce until December 2025.
- Artige and Ritalin Immediate-Release Tablets: Previously affected, but the shortages have now been resolved.
Causes of the Shortage
The shortages are primarily due to global manufacturing issues and increased demand. Australia’s reliance on imported medications—approximately 90% of its pharmaceuticals—makes it particularly vulnerable to international supply disruptions.
ADHD Medication Shortages: What You Need to Know
Impact on Patients and Healthcare Providers
The shortages have led to significant challenges for patients, especially children and teenagers, who are experiencing difficulties in maintaining their treatment regimens . Healthcare providers are often forced to switch patients to alternative medications, which may not be as effective or may have different side effect profiles.
Steps Being Taken
- Therapeutic Goods Administration (TGA): The TGA is closely monitoring the situation and has approved the supply of certain overseas-registered products under Section 19A to mitigate the impact of shortages.
- Healthcare Providers: Doctors are working to find suitable alternatives for patients and are advising them to consult with their healthcare providers to discuss treatment options.
- Calls for Policy Changes: There is growing advocacy for a national strategy to address medication shortages and for expanding the prescribing powers of general practitioners to improve access to ADHD medications.
Recommendations for Patients
- Consult Healthcare Providers: If you are affected by the shortages, speak with your doctor or pharmacist about alternative treatment options.
- Plan Ahead: Given the ongoing nature of the shortages, it’s advisable to plan your medication needs in advance and maintain open communication with your healthcare providers.
- Stay Informed: Keep up to date with information from reliable sources such as the TGA and your local health authorities.
- For the most current information on medication availability, visit the TGA’s medicine shortages database